These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 13512076)

  • 1. [Cytostatic treatment of malignant tumors with alcoxyethyleneimino-benzoquinone; Bayer E 39].
    SCHWERMER B; SCHREIBER HW
    Dtsch Med Wochenschr; 1958 Feb; 83(9):331-8. PubMed ID: 13512076
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cytotoxic drugs and malignant tumors; action of triethylene melamine, of diethylene-dipropryloxy-benzoquinone and of thiophosphoramide].
    RAVINA A; PESTEL M
    Presse Med (1893); 1958 Mar; 66(17):371-4. PubMed ID: 13542572
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative study of human malignant tumoral diseases of the therapeutic activity of two newderivatives of ethyleniminoquinone: 3,6-bis 2-methoxyethyl)-& 3, 6-bis(acetylamino)-2, 5-bis(1-aziridinyl)-p-benzoquinone].
    BERNARD J; MATHE G; WEIL M
    Bull Assoc Fr Etud Cancer; 1959; 46(1):34-74. PubMed ID: 13671261
    [No Abstract]   [Full Text] [Related]  

  • 4. [Preliminary report on the treatment of plasmocytoma with an ethyleneimino-quinone preparation (E 39 Bayer)].
    HEILMANN D
    Dtsch Med J; 1957 Nov; 8(11):565-9. PubMed ID: 13490130
    [No Abstract]   [Full Text] [Related]  

  • 5. [SUCCESSFUL RESULT OF THE USE OF CYTOSTATIC DRUGS OF THE ETHYLENEIMINO-BENZOQUINONE GROUP IN THE TREATMENT OF CANCER OF THE UTERINE CERVIX].
    LUCER C; SZLAZAK W
    Pol Tyg Lek; 1965 Jan; 20():70-1. PubMed ID: 14331136
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical findings on 2, 5-dipropoxy-3, 6-bis-ethylenimino-p-benzoquinone].
    PEDERZINI A; SCARDOVI GA; REZZATTI I
    Prog Med (Napoli); 1959 Mar; 15(5):143-9. PubMed ID: 13667953
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of the cytotoxic drug Bayer E 39 in malignant tumors of the eyelids].
    PILLAT A
    Wien Klin Wochenschr; 1958 May; 70(21):383-6. PubMed ID: 13570068
    [No Abstract]   [Full Text] [Related]  

  • 8. [PHYTOBIOLOGICAL EVALUATION OF THE CYTOSTATIC EFFECT OF ETHYLENEIMINO-1,4-BENZOQUINONES USED IN CANCER CHEMOTHERAPY].
    CONSTANTINESCU DG; RETEZEANU M; OTELEANU R; CONSTANTINESCU M
    Pharmazie; 1963 Oct; 18():699-703. PubMed ID: 14204170
    [No Abstract]   [Full Text] [Related]  

  • 9. [Local treatment of malignant eyelid tumors with Bayer E 39].
    PILLAT A
    Krebsarzt; 1958 Jan; 13(1):30-5. PubMed ID: 13526248
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prolonged oral medication of Bayer E39 (cytostatic)].
    HESSE F; KAMPEN G
    Krebsarzt; 1957 Jun; 12(3):150-6. PubMed ID: 13450292
    [No Abstract]   [Full Text] [Related]  

  • 11. [Critical observations on therapy of malignancy with the cytostatic Bayer A 139 in otorhinolaryngological therapeutics].
    NIEMEYER W
    Dtsch Med J; 1958 Jul; 9(7):387-9. PubMed ID: 13561805
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical experiences with cytostatic treatment of malignant tumors with E 39 & A 139 (Bayer)].
    SEGSCHNEIDER PP; STROBEL E
    Munch Med Wochenschr; 1958 Dec; 100(51):2011-3. PubMed ID: 13622558
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical experiences with ethyleneimino-quinone (E 39) in chemotherapy of various neoplasms].
    DI PIETRO S
    Riforma Med; 1957 Jun; 71(22):608-14. PubMed ID: 13454502
    [No Abstract]   [Full Text] [Related]  

  • 14. [Attempted treatment of advanced cancer with a derivative of the ethylene-imine-quinone group (E 39 or 6870 RP)].
    JANBON M; BERTRAND L; BERTRAND A; FLANDRE O
    Montp Med; 1958 Jun; 53(6):863-4. PubMed ID: 13589947
    [No Abstract]   [Full Text] [Related]  

  • 15. [The role of pH in the effect of two ethyleneimine quinones (Bayer E 39 and Bayer A 139) on nucleic acids].
    SCHOLTISSEK C
    Z Krebsforsch; 1957; 62(2):109-11. PubMed ID: 13531429
    [No Abstract]   [Full Text] [Related]  

  • 16. [Observation of bone marrow function in cytostatic treatment of malignant tumors].
    KRATZSCH E; SCHMERMUND HJ
    Med Klin; 1959 Jul; 54(27):1238-40. PubMed ID: 13673975
    [No Abstract]   [Full Text] [Related]  

  • 17. [Failure of attempted treatment of multiregional lymphosarcomatosis with the new antitumoral quinone E 39].
    MOULINIER J
    J Med Bord; 1957 Jul; 134(7):953-6. PubMed ID: 13449493
    [No Abstract]   [Full Text] [Related]  

  • 18. [First results concerning the effects of the cytostatic drug Bayer E-39].
    VERGA P; PERRONE V
    Riforma Med; 1957 Jun; 71(22):604-7. PubMed ID: 13454501
    [No Abstract]   [Full Text] [Related]  

  • 19. [Peculiarities in the course of malignant diseases of the hemopoietic & lymphoreticular systems under cytostatic treatment].
    SIEGENTHALER W; KEISER G; ZOLLINGER HU
    Z Klin Med; 1959; 155(6):568-601. PubMed ID: 13648600
    [No Abstract]   [Full Text] [Related]  

  • 20. [First therapeutic trials with the ethylene-quinone E 39].
    OLMER J
    Mars Med; 1957; 94(7):499-502. PubMed ID: 13482462
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.